Invesco Biotechnology & Genome ETF Rating $65.54 +0.24 (+0.37%) Closing price 08/1/2025 04:10 PM EasternExtended Trading$65.41 -0.13 (-0.20%) As of 04:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ratings Stock AnalysisChartDividendHoldingsOwnershipRatingsShort InterestBuy This Stock Invesco Biotechnology & Genome ETF Aggregate Rating and Price Target (2025)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.PBE Aggregate RatingModerate Buy 2.67Holdings in PBE have an aggregate rating of Moderate Buy based on 362 analyst ratings issued in the past year covering 25 companies (88.3% of the portfolio).PBE Aggregate Price Target$65.54High Prediction$65.54Average Prediction$65.54Low Prediction$65.54Holdings in PBE have an aggregate price target of $65.54 and a range of $65.54 to $65.54 covering 25 companies (88.3% of the portfolio).PBE Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy3 Buy rating(s)Moderate Buy16 Moderate Buy rating(s)Hold6 Hold rating(s)Reduce0 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by Invesco Biotechnology & Genome ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 PBE Holdings Export to ExcelWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings5.53%ILMNIllumina$94.66-7.8%4.932 of 5 stars2.40$127.21 34.4%20Trending NewsEarnings ReportAnalyst ForecastAnalyst RevisionGap Down5.18%ALNYAlnylam Pharmaceuticals$401.80+2.4%3.8477 of 5 stars2.81$392.13 -2.4%26Trending NewsAnalyst Forecast5.14%RPRXRoyalty Pharma$37.11+0.8%4.9232 of 5 stars3.25$49.00 32.0%4Positive NewsUpcoming Earnings5.03%VRTXVertex Pharmaceuticals$462.13+1.2%4.3382 of 5 stars2.50$509.89 10.3%26Positive NewsShort Interest ↑4.97%AMGNAmgen$296.88+0.6%4.5796 of 5 stars2.35$307.27 3.5%23Positive NewsUpcoming EarningsDividend Announcement4.86%GILDGilead Sciences$113.18+0.8%4.6314 of 5 stars2.81$112.36 -0.7%26Positive NewsUpcoming Earnings4.81%BMRNBioMarin Pharmaceutical$58.14+0.5%4.9771 of 5 stars2.75$93.74 61.2%24High Trading Volume4.47%UTHRUnited Therapeutics$294.28+7.1%4.9601 of 5 stars2.69$379.69 29.0%13Trending NewsEarnings ReportShort Interest ↑Analyst RevisionGap UpHigh Trading Volume3.73%AVXLAnavex Life Sciences$11.20-0.9%3.5318 of 5 stars3.00$44.00 292.9%2Upcoming EarningsGap Down3.28%BPMCBlueprint Medicines$129.460.7044 of 5 stars2.11$130.00 0.4%18Upcoming Earnings3.14%ARWRArrowhead Pharmaceuticals$15.93+0.8%3.8069 of 5 stars2.89$43.71 174.4%9Positive NewsUpcoming EarningsGap Up2.94%CDNACareDx$12.22-0.5%4.1452 of 5 stars2.67$29.33 140.0%6Positive NewsUpcoming EarningsAnalyst Downgrade2.88%PTGXProtagonist Therapeutics$53.83-0.1%2.1288 of 5 stars3.00$66.10 22.8%9News CoveragePositive NewsUpcoming Earnings2.82%DVAXDynavax Technologies$10.86-1.1%4.2698 of 5 stars2.50$24.00 121.0%4Upcoming Earnings2.80%COLLCollegium Pharmaceutical$30.07+0.7%4.0108 of 5 stars2.75$43.75 45.5%4Upcoming Earnings2.79%QGENQIAGEN$49.90+1.1%3.204 of 5 stars2.30$49.40 -1.0%10Upcoming EarningsAnalyst Upgrade2.78%NBIXNeurocrine Biosciences$128.91+0.5%4.6881 of 5 stars2.86$160.90 24.8%22Trending NewsEarnings ReportAnalyst ForecastAnalyst Revision2.75%TGTXTG Therapeutics$35.02-1.4%4.1379 of 5 stars2.80$43.80 25.1%5Positive News2.71%RGENRepligen$118.91+1.6%4.6956 of 5 stars2.67$169.45 42.5%12Trending NewsEarnings ReportAnalyst Revision2.69%INCYIncyte$75.59+0.9%4.751 of 5 stars2.28$79.73 5.5%18Trending NewsAnalyst Forecast2.66%HALOHalozyme Therapeutics$59.02-1.6%4.771 of 5 stars2.17$62.70 6.2%12Positive NewsUpcoming Earnings2.63%FOLDAmicus Therapeutics$6.32+5.5%3.9923 of 5 stars2.80$16.22 156.7%10Trending NewsAnalyst Upgrade2.61%EXELExelixis$37.26+2.9%4.9461 of 5 stars2.55$44.44 19.3%22Trending NewsEarnings ReportAnalyst DowngradeAnalyst Revision2.60%PTCTPTC Therapeutics$52.13+0.0%4.482 of 5 stars2.67$69.38 33.1%15Trending NewsUpcoming Earnings2.50%EXASExact Sciences$47.76+1.7%4.4349 of 5 stars2.95$70.50 47.6%22Positive NewsUpcoming Earnings This page (NYSEARCA:PBE) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredWall Street Laughed. Now They're Buying.For six months, I’ve been pounding the table on a major gold miner—while Twitter pundits laughed. But now, the...Golden Portfolio | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Create New Advertiser | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredTrump’s biggest move, misreportedThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Invesco Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Invesco Biotechnology & Genome ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free PBE Stock Alerts